Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE


NEW YORK, May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Sage and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On April 17, 2024, Sage issued a press release "announc[ing] . . . topline results from PRECEDENT, a double-blind, placebo-controlled Phase 2 study of the investigational oral medicine dalzanemdor (SAGE-718) in people with mild cognitive impairment (MCI) in Parkinson's Disease (PD)."  Sage stated that "[t]he PRECEDENT Study did not meet its primary endpoint of demonstrating statistically significant difference from baseline in participants treated with once-daily dalzanemdor versus placebo". 

On this news, Sage's stock price fell $3.06 per share, or 19.58%, to close at $12.57 per share on April 17, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 14:08
OPSEU/SEFPO President JP Hornick is at the Ontario Science Centre this afternoon with Science Centre workers amidst news that it will be immediately shut down by the Ford government. Media availability today, June 21, 2024: 2 p.m. ? 4 p.m. Hornick...

at 14:07
Magna5 has been named one of the world's top-performing managed service providers (MSPs) in the prestigious 2024 Channel Futures MSP 501 rankings. This list, a benchmark in the technology industry, ranks companies based on growth, profitability, and...

at 14:00
A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Mutual Fund Dealer Rules to consider a settlement agreement entered into between Enforcement Staff and Gulnar Carlisle....

at 14:00
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lamb Weston Holdings, Inc. ("Lamb Weston" or "the Company") and certain of its officers....

at 14:00
The Government of Canada is committed to helping Canadian creative businesses and organizations enhance their visibility and increase their profits in global markets, benefiting Canada's creative professionals and our economy. The Honourable Pascale...

at 14:00
Media are invited to join the Honourable Ginette Petitpas Taylor, Minister of Veteran Affairs and Associate Minister of National Defence and Member of Parliament for Moncton-Riverview-Dieppe on behalf of the Honourable Sean Fraser, Minister of...



News published on and distributed by: